Trials / Completed
CompletedNCT04804514
Evaluation of the Safety and Tolerability of KH001 in Dentin Hypersensitivity Patients
Phase 1/2a Study of KH001 in Dentin Hypersensitivity Patients
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- HysensBio Co., Ltd · Industry
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase 1/2a study in dentin hypersensitivity patients to assess the safety, tolerability, efficacy and pharmacokinetics of single and multiple doses of KH001.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KH001 | The study drug is applied to teeth |
| DRUG | Placebo | The placebo is applied to teeth |
Timeline
- Start date
- 2021-06-14
- Primary completion
- 2023-03-03
- Completion
- 2023-03-03
- First posted
- 2021-03-18
- Last updated
- 2025-02-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04804514. Inclusion in this directory is not an endorsement.